预防膀胱癌患者发生静脉血栓栓塞的研究进展

Advances on prevention of venous thromboembolism in patients with bladder cancer

众所周知,癌症是发生血栓的一个重要危险因素。静脉血栓栓塞(VTE)包括肺栓塞和深静脉血栓形成,是常见的由恶性肿瘤引起的血管疾病。膀胱癌患者在诊断后5年内发生VTE的概率约8%,明显高于其他恶性肿瘤。VTE发病率与患者的特定特征相关,如年龄、疾病阶段和治疗方式等,而不仅取决于是否手术。膀胱癌患者的血栓防治并非没有风险,但可以为疾病预后提供指导和决策。

As we all know,cancer is an important risk factor for thrombosis.Venous thromboembolism(VTE),including pulmonary embolism and deep vein thrombosis,is the common vascular disease caused by malignant tumors.Studies have shown that patients with bladder cancer have almost 8%probability of developing VTE within 5 years of diagnosis,which is higher than other malignant tumors.The incidence of VTE is associated with specific features,such as age,disease stage,and treatment,but not just with whether surgery.Although the therapy has risks,it can provide guidance and decision for the prognosis in bladder cancer patients.